RGCRegencell Bioscience Holdings Ltd$6.20Sep 29 close+0.3%1M+12.6%6M-73.4%1Y-59.9%5Y+1,192.8%

Overview Financials Earnings Peers Projection Compare

Loading company

Every figure taken straight from a company’s own SEC filings, with the checks behind each grade shown — and whatever could not be found named rather than hidden.

Appearance

Product

Screener
Earnings calendar
Watchlists
Portfolios

Browse

Rankings
Free this week
Industries
Themed lists
Fund managers

Company

About
How the grade works
Glossary
Pricing
Contact

Legal

Terms of service
Privacy policy
Disclaimer
Cookie policy

InspectStocks describes businesses using their own reported figures. It is not investment advice and does not recommend buying or selling anything.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Regencell Bioscience Holdings Ltd (RGC) latest earnings — what was reported — InspectStocks

RGCRegencell Bioscience Holdings Ltd$6.20Sep 29 close+0.3%1M+12.6%6M-73.4%1Y-59.9%5Y+1,192.8%

Overview Financials Earnings Peers Projection Compare

Regencell Bioscience Holdings Ltd

RGC · Nasdaq · ·

Next earnings: October 30, 2026

$6.20+0.3%Sep 29 close

1M: +12.6%
6M: -73.4%
1Y: -59.9%
5Y: +1,192.8%

Compare

Healthcare

Drug Manufacturers Specialty and Generic

Regencell Bioscience Holdings Ltd is scheduled to report next on October 30, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.

We hold no quarterly figures or earnings release for Regencell Bioscience Holdings Ltd yet. Releases are read from a company’s Item 2.02 8-K or, for a foreign filer, the 6-K that carries its results.

Earnings calls

Regencell Bioscience Holdings Ltd has no earnings call transcript available.